NYSE:HUM - New York Stock Exchange, Inc. - US4448591028 - Common Stock - Currency: USD
HUMANA INC
NYSE:HUM (1/30/2025, 6:40:00 PM)
After market: 296.91 0 (0%)296.91
+2.68 (+0.91%)
The current stock price of HUM is 296.91 USD. In the past month the price increased by 16.77%. In the past year, price decreased by -21.63%.
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.
The company revised its full-year 2025 adjusted EPS to $29.50, below the $31.48 estimate, and projected adjusted revenue of at least $252 billion.
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 19.54 | 502.08B | ||
ELV | ELEVANCE HEALTH INC | 12.11 | 92.61B | ||
CNC | CENTENE CORP | 9.57 | 32.62B | ||
MOH | MOLINA HEALTHCARE INC | 14.24 | 17.90B | ||
HQY | HEALTHEQUITY INC | 36.02 | 9.58B | ||
ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.91B | ||
CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.22B | ||
PGNY | PROGYNY INC | 40.59 | 2.00B | ||
NEUE | NEUEHEALTH INC | 5.56 | 60.85M |
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,600 full-time employees. The company operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. The company also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. The company also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. The company also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
HUMANA INC
500 W Main St
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 67600
Company Website: https://www.humana.com/
Investor Relations: https://humana.gcs-web.com/
Phone: 15025801000
The current stock price of HUM is 296.91 USD.
The exchange symbol of HUMANA INC is HUM and it is listed on the New York Stock Exchange, Inc. exchange.
HUM stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for HUM, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of HUM.
HUM has a dividend yield of 1.2%. The yearly dividend amount is currently 3.49.
HUM will report earnings on 2025-02-11, after the market close.
The PE ratio for HUM is 16.28. This is based on the reported non-GAAP earnings per share of 18.24 and the current share price of 296.91 USD.
The outstanding short interest for HUM is 4.65% of its float.
ChartMill assigns a technical rating of 5 / 10 to HUM. When comparing the yearly performance of all stocks, HUM is a bad performer in the overall market: 73.32% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to HUM. HUM has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 18.24. The EPS increased by -34.2% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.18% | ||
ROA | 2.72% | ||
ROE | 7.74% | ||
Debt/Equity | 0.68 |
ChartMill assigns a Buy % Consensus number of 69% to HUM. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of -37.24% and a revenue growth 13.06% for HUM